A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda.
Identifieur interne : 005129 ( Main/Exploration ); précédent : 005128; suivant : 005130A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda.
Auteurs : Harriet Namwanje [Ouganda] ; Narcis Kabatereine ; Annette OlsenSource :
- Transactions of the Royal Society of Tropical Medicine and Hygiene [ 1878-3503 ] ; 2011.
Descripteurs français
- KwdFr :
- Adolescent, Albendazole (administration et posologie), Albendazole (économie), Analyse coût-bénéfice, Animaux, Antiparasitaires (administration et posologie), Antiparasitaires (économie), Association de médicaments (), Enfant, Enfant d'âge préscolaire, Femelle, Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (économie), Filariose lymphatique (épidémiologie), Helminthiase (traitement médicamenteux), Helminthiase (économie), Helminthiase (épidémiologie), Humains, Ivermectine (administration et posologie), Ivermectine (économie), Mâle, Méthode en simple aveugle, Ouganda (épidémiologie), Praziquantel (administration et posologie), Praziquantel (économie), Résultat thérapeutique, Schistosomiase (traitement médicamenteux), Schistosomiase (économie), Schistosomiase (épidémiologie), Surveillance sentinelle.
- MESH :
- administration et posologie : Albendazole, Antiparasitaires, Ivermectine, Praziquantel.
- traitement médicamenteux : Filariose lymphatique, Helminthiase, Schistosomiase.
- économie : Albendazole, Antiparasitaires, Filariose lymphatique, Helminthiase, Ivermectine, Praziquantel, Schistosomiase.
- épidémiologie : Filariose lymphatique, Helminthiase, Ouganda, Schistosomiase.
- Adolescent, Analyse coût-bénéfice, Animaux, Association de médicaments, Enfant, Enfant d'âge préscolaire, Femelle, Humains, Mâle, Méthode en simple aveugle, Résultat thérapeutique, Surveillance sentinelle.
- Wicri :
- geographic : Ouganda.
English descriptors
- KwdEn :
- Adolescent, Albendazole (administration & dosage), Albendazole (economics), Animals, Antiparasitic Agents (administration & dosage), Antiparasitic Agents (economics), Child, Child, Preschool, Cost-Benefit Analysis, Drug Therapy, Combination (methods), Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (economics), Elephantiasis, Filarial (epidemiology), Female, Helminthiasis (drug therapy), Helminthiasis (economics), Helminthiasis (epidemiology), Humans, Ivermectin (administration & dosage), Ivermectin (economics), Male, Praziquantel (administration & dosage), Praziquantel (economics), Schistosomiasis (drug therapy), Schistosomiasis (economics), Schistosomiasis (epidemiology), Sentinel Surveillance, Single-Blind Method, Treatment Outcome, Uganda (epidemiology).
- MESH :
- chemical , administration & dosage : Albendazole, Antiparasitic Agents, Ivermectin, Praziquantel.
- chemical , economics : Albendazole, Antiparasitic Agents, Ivermectin, Praziquantel.
- geographic , epidemiology : Uganda.
- drug therapy : Elephantiasis, Filarial, Helminthiasis, Schistosomiasis.
- economics : Elephantiasis, Filarial, Helminthiasis, Schistosomiasis.
- epidemiology : Elephantiasis, Filarial, Helminthiasis, Schistosomiasis.
- methods : Drug Therapy, Combination.
- Adolescent, Animals, Child, Child, Preschool, Cost-Benefit Analysis, Female, Humans, Male, Sentinel Surveillance, Single-Blind Method, Treatment Outcome.
Abstract
Integrated chemotherapy of neglected tropical diseases (NTD) through mass drug administration given as a single dose would increase treatment coverage and cost-effectiveness. This study reports on the safety of a combination of albendazole, ivermectin and praziquantel in the treatment of lymphatic filariasis (LF), schistosomiasis and soil-transmitted helminthiasis (STH) in infected children. In this randomised, controlled, single-blinded clinical trial conducted in 235 primary school children aged 5-18 years in Yumbe District in Northern Uganda, the triple combination therapy was compared with the current NTD programme regimen. Liver function testing was performed for all children who received combined therapy. The study included 48 children with LF alone, 60 children with schistosomiasis (Schistosoma mansoni), 41 children with STH, 49 children with schistosomiasis + LF and 37 children with all three types of infection. Children were closely monitored by a paediatrician for any adverse reactions for 7 days. No serious adverse events were experienced. However, 4 of 18 children in the test group and 2 of 3 children in the control group who did not report any ill conditions before treatment developed adverse drug reactions. The combined and conventional therapies were found to be equally safe. The efficacies of both therapies were comparable and satisfactory. [ClinicalTrials.gov identifier: NCT01050517].
DOI: 10.1016/j.trstmh.2010.11.012
PubMed: 21353271
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002734
- to stream PubMed, to step Curation: 002734
- to stream PubMed, to step Checkpoint: 002734
- to stream Ncbi, to step Merge: 004158
- to stream Ncbi, to step Curation: 004158
- to stream Ncbi, to step Checkpoint: 004158
- to stream Main, to step Merge: 005168
- to stream Main, to step Curation: 005129
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda.</title><author><name sortKey="Namwanje, Harriet" sort="Namwanje, Harriet" uniqKey="Namwanje H" first="Harriet" last="Namwanje">Harriet Namwanje</name><affiliation wicri:level="1"><nlm:affiliation>Vector Control Division, Ministry of Health, P.O. Box 1661, Kampala, Uganda. harrietlwanga@ymail.com</nlm:affiliation><country xml:lang="fr">Ouganda</country><wicri:regionArea>Vector Control Division, Ministry of Health, P.O. Box 1661, Kampala</wicri:regionArea><wicri:noRegion>Kampala</wicri:noRegion></affiliation></author><author><name sortKey="Kabatereine, Narcis" sort="Kabatereine, Narcis" uniqKey="Kabatereine N" first="Narcis" last="Kabatereine">Narcis Kabatereine</name></author><author><name sortKey="Olsen, Annette" sort="Olsen, Annette" uniqKey="Olsen A" first="Annette" last="Olsen">Annette Olsen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21353271</idno><idno type="pmid">21353271</idno><idno type="doi">10.1016/j.trstmh.2010.11.012</idno><idno type="wicri:Area/PubMed/Corpus">002734</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002734</idno><idno type="wicri:Area/PubMed/Curation">002734</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002734</idno><idno type="wicri:Area/PubMed/Checkpoint">002734</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002734</idno><idno type="wicri:Area/Ncbi/Merge">004158</idno><idno type="wicri:Area/Ncbi/Curation">004158</idno><idno type="wicri:Area/Ncbi/Checkpoint">004158</idno><idno type="wicri:Area/Main/Merge">005168</idno><idno type="wicri:Area/Main/Curation">005129</idno><idno type="wicri:Area/Main/Exploration">005129</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda.</title><author><name sortKey="Namwanje, Harriet" sort="Namwanje, Harriet" uniqKey="Namwanje H" first="Harriet" last="Namwanje">Harriet Namwanje</name><affiliation wicri:level="1"><nlm:affiliation>Vector Control Division, Ministry of Health, P.O. Box 1661, Kampala, Uganda. harrietlwanga@ymail.com</nlm:affiliation><country xml:lang="fr">Ouganda</country><wicri:regionArea>Vector Control Division, Ministry of Health, P.O. Box 1661, Kampala</wicri:regionArea><wicri:noRegion>Kampala</wicri:noRegion></affiliation></author><author><name sortKey="Kabatereine, Narcis" sort="Kabatereine, Narcis" uniqKey="Kabatereine N" first="Narcis" last="Kabatereine">Narcis Kabatereine</name></author><author><name sortKey="Olsen, Annette" sort="Olsen, Annette" uniqKey="Olsen A" first="Annette" last="Olsen">Annette Olsen</name></author></analytic><series><title level="j">Transactions of the Royal Society of Tropical Medicine and Hygiene</title><idno type="eISSN">1878-3503</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Albendazole (administration & dosage)</term><term>Albendazole (economics)</term><term>Animals</term><term>Antiparasitic Agents (administration & dosage)</term><term>Antiparasitic Agents (economics)</term><term>Child</term><term>Child, Preschool</term><term>Cost-Benefit Analysis</term><term>Drug Therapy, Combination (methods)</term><term>Elephantiasis, Filarial (drug therapy)</term><term>Elephantiasis, Filarial (economics)</term><term>Elephantiasis, Filarial (epidemiology)</term><term>Female</term><term>Helminthiasis (drug therapy)</term><term>Helminthiasis (economics)</term><term>Helminthiasis (epidemiology)</term><term>Humans</term><term>Ivermectin (administration & dosage)</term><term>Ivermectin (economics)</term><term>Male</term><term>Praziquantel (administration & dosage)</term><term>Praziquantel (economics)</term><term>Schistosomiasis (drug therapy)</term><term>Schistosomiasis (economics)</term><term>Schistosomiasis (epidemiology)</term><term>Sentinel Surveillance</term><term>Single-Blind Method</term><term>Treatment Outcome</term><term>Uganda (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term><term>Albendazole (administration et posologie)</term><term>Albendazole (économie)</term><term>Analyse coût-bénéfice</term><term>Animaux</term><term>Antiparasitaires (administration et posologie)</term><term>Antiparasitaires (économie)</term><term>Association de médicaments ()</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Filariose lymphatique (traitement médicamenteux)</term><term>Filariose lymphatique (économie)</term><term>Filariose lymphatique (épidémiologie)</term><term>Helminthiase (traitement médicamenteux)</term><term>Helminthiase (économie)</term><term>Helminthiase (épidémiologie)</term><term>Humains</term><term>Ivermectine (administration et posologie)</term><term>Ivermectine (économie)</term><term>Mâle</term><term>Méthode en simple aveugle</term><term>Ouganda (épidémiologie)</term><term>Praziquantel (administration et posologie)</term><term>Praziquantel (économie)</term><term>Résultat thérapeutique</term><term>Schistosomiase (traitement médicamenteux)</term><term>Schistosomiase (économie)</term><term>Schistosomiase (épidémiologie)</term><term>Surveillance sentinelle</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Albendazole</term><term>Antiparasitic Agents</term><term>Ivermectin</term><term>Praziquantel</term></keywords><keywords scheme="MESH" type="chemical" qualifier="economics" xml:lang="en"><term>Albendazole</term><term>Antiparasitic Agents</term><term>Ivermectin</term><term>Praziquantel</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Uganda</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Albendazole</term><term>Antiparasitaires</term><term>Ivermectine</term><term>Praziquantel</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Helminthiasis</term><term>Schistosomiasis</term></keywords><keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Helminthiasis</term><term>Schistosomiasis</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Elephantiasis, Filarial</term><term>Helminthiasis</term><term>Schistosomiasis</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Drug Therapy, Combination</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term><term>Helminthiase</term><term>Schistosomiase</term></keywords><keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Albendazole</term><term>Antiparasitaires</term><term>Filariose lymphatique</term><term>Helminthiase</term><term>Ivermectine</term><term>Praziquantel</term><term>Schistosomiase</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Filariose lymphatique</term><term>Helminthiase</term><term>Ouganda</term><term>Schistosomiase</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Animals</term><term>Child</term><term>Child, Preschool</term><term>Cost-Benefit Analysis</term><term>Female</term><term>Humans</term><term>Male</term><term>Sentinel Surveillance</term><term>Single-Blind Method</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term><term>Analyse coût-bénéfice</term><term>Animaux</term><term>Association de médicaments</term><term>Enfant</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Méthode en simple aveugle</term><term>Résultat thérapeutique</term><term>Surveillance sentinelle</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ouganda</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Integrated chemotherapy of neglected tropical diseases (NTD) through mass drug administration given as a single dose would increase treatment coverage and cost-effectiveness. This study reports on the safety of a combination of albendazole, ivermectin and praziquantel in the treatment of lymphatic filariasis (LF), schistosomiasis and soil-transmitted helminthiasis (STH) in infected children. In this randomised, controlled, single-blinded clinical trial conducted in 235 primary school children aged 5-18 years in Yumbe District in Northern Uganda, the triple combination therapy was compared with the current NTD programme regimen. Liver function testing was performed for all children who received combined therapy. The study included 48 children with LF alone, 60 children with schistosomiasis (Schistosoma mansoni), 41 children with STH, 49 children with schistosomiasis + LF and 37 children with all three types of infection. Children were closely monitored by a paediatrician for any adverse reactions for 7 days. No serious adverse events were experienced. However, 4 of 18 children in the test group and 2 of 3 children in the control group who did not report any ill conditions before treatment developed adverse drug reactions. The combined and conventional therapies were found to be equally safe. The efficacies of both therapies were comparable and satisfactory. [ClinicalTrials.gov identifier: NCT01050517].</div></front></TEI><affiliations><list><country><li>Ouganda</li></country></list><tree><noCountry><name sortKey="Kabatereine, Narcis" sort="Kabatereine, Narcis" uniqKey="Kabatereine N" first="Narcis" last="Kabatereine">Narcis Kabatereine</name><name sortKey="Olsen, Annette" sort="Olsen, Annette" uniqKey="Olsen A" first="Annette" last="Olsen">Annette Olsen</name></noCountry><country name="Ouganda"><noRegion><name sortKey="Namwanje, Harriet" sort="Namwanje, Harriet" uniqKey="Namwanje H" first="Harriet" last="Namwanje">Harriet Namwanje</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005129 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005129 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21353271
|texte= A randomised controlled clinical trial on the safety of co-administration of albendazole, ivermectin and praziquantel in infected schoolchildren in Uganda.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21353271" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |